Male, n (%)
|
108 (75.0)
|
37 (60.7)
|
0.039
|
Age, years
|
64.8 ± 10.3
|
65.3 ± 9.1
|
0.728
|
Body mass index, Kg/m2
|
25.5 ± 3.4
|
24.9 ± 3.1
|
0.262
|
Smoking, n (%)
|
50 (34.7)
|
11 (18.0)
|
0.017
|
Hypertension (%)
|
110 (76.4)
|
37 (60.7)
|
0.022
|
Systolic blood pressure, mmHg
|
140 ± 19
|
139 ± 20
|
0.572
|
Diastolic blood pressure,mmHg
|
81 ± 12
|
81 ± 11
|
0.603
|
Dyslipidemia history, n (%)
|
57 (39.6)
|
23 (37.7)
|
0.801
|
Triglycerides, mmol/L
|
1.82 ± 1.09
|
1.75 ± 0.96
|
0.671
|
Total cholesterol, mmol/L
|
4.3 ± 1.2
|
4.4 ± 1.0
|
0.753
|
HDL cholesterol, mmol/L
|
1.01 ± 0.24
|
1.13 ± 0.22
|
0.001
|
LDL cholesterol, mmol/L
|
2.63 ± 0.93
|
2.56 ± 0.76
|
0.616
|
Lipoprotein (a), g/L
|
0.27 ± 0.25
|
0.28 ± 0.26
|
0.666
|
Apoprotein A, g/L
|
1.20 ± 0.19
|
1.23 ± 0.20
|
0.310
|
Apoprotein B, g/L
|
0.91 ± 0.26
|
0.88 ± 0.20
|
0.460
|
Serum creatinine, μmol/L
|
81 ± 17
|
75 ± 14
|
0.011
|
eGFR, mL/min/1.73 m2
|
92.3 ± 24.4
|
96.8 ± 23.6
|
0.228
|
Uric acid, μmol/L
|
342 ± 89
|
325 ± 83
|
0.199
|
Fasting blood glucose, mmol/L
|
6.79 ± 2.00
|
6.02 ± 1.33
|
0.001
|
HbA1c, %
|
7.81 ± 1.07
|
6.89 ± 0.75
|
<0.001
|
hsCRP, mg/L
|
6.20 ± 3.24
|
5.21 ± 2.42
|
0.040
|
Extent index
|
0.48 ± 0.13
|
0.27 ± 0.08
|
<0.001
|
Cumulative coronary stenosis score
|
2.17 ± 0.71
|
0.92 ± 0.42
|
<0.001
|
Relative intensity of apoA-I glycation, %
|
8.27 ± 2.09
|
5.69 ± 1.42
|
<0.001
|
Activities of paraoxonase, U/mL
|
Serum PON1 activity
|
78.46 ± 16.94
|
86.01 ± 17.36
|
0.004
|
HDL-associated PON1 activity
|
41.43 ± 14.64
|
92.19 ± 33.42
|
<0.001
|
Serum PON3 activity
|
32.15 ± 5.33
|
39.2 ± 6.62
|
<0.001
|
HDL-associated PON3 activity
|
26.06 ± 12.66
|
64.58 ± 22.44
|
<0.001
|
Medical treatments, n (%)
|
Insulins
|
51 (35.4)
|
11 (18.0)
|
0.013
|
Metformin
|
70 (48.6)
|
31 (50.8)
|
0.772
|
Sulphonylurea
|
41 (28.5)
|
25 (41.0)
|
0.080
|
α-Glucosidase
|
40 (27.8)
|
18 (29.5)
|
0.801
|
Statin
|
107 (74.3)
|
43 (70.5)
|
0.573
|
ACE inhibitor/ARB
|
88 (61.1)
|
37 (60.7)
|
0.951
|
β-blocker
|
82 (56.9)
|
34 (55.7)
|
0.873
|
Calcium channel blocker
|
73 (50.7)
|
39 (63.9)
|
0.082
|
Antiplatelet
|
107 (74.3)
|
36 (59.0)
|
0.029
|